Product Program year 2020 Source: CMS Open Payments

Visia AF

Device Implantable Cardioverter Defibrillators (ICDs)

Open in the dashboard

General payments

$49,833

1,454 payments

Research payments

$0

0 payments

Through program year 2020, $49,833 in general payments and $0 in research payments were reported against Visia AF (Implantable Cardioverter Defibrillators (ICDs)).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2020 General $6,559 347
2019 General $43,274 1,107

Breakdown

Who paid General payments · program years 2019–2020
  1. Medtronic Vascular, Inc. $49,478 1,423 payments
  2. Medtronic, Inc. $355 31 payments
Top recipients General payments · program year 2020
  1. Alan Yeung Interventional Cardiology · Stanford, CA $177 3% · 1 payment
  2. William Fearon Interventional Cardiology · Stanford, CA $177 3% · 1 payment
  3. James Bensler Cardiovascular Disease · Jackson, MS $167 3% · 1 payment
  4. Zalmen Blanck Clinical Cardiac Electrophysiology · San Antonio, TX $149 2% · 6 payments
  5. Steven Stevens Clinical Cardiac Electrophysiology · Bethlehem, PA $140 2% · 1 payment

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2020.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2020
  1. Clinical Cardiac Electrophysiology Internal Medicine $2,698 42% · 103 practitioners
  2. Cardiovascular Disease Internal Medicine $2,127 33% · 82 practitioners
  3. Interventional Cardiology Internal Medicine $1,274 20% · 36 practitioners
  4. Thoracic Surgery (Cardiothoracic Vascular Surgery) $140 2% · 1 practitioner
  5. Internal Medicine $57 <1% · 3 practitioners

The top 5 of 13 specialties; each share is of general payments naming this product to practitioners with a specialty in 2020. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2020
  1. Texas $1,175 18% · 42 recipients
  2. Florida $998 15% · 29 recipients
  3. California $696 11% · 26 recipients
  4. New Jersey $504 8% · 20 recipients
  5. Missouri $311 5% · 10 recipients

The top 5 of 27 states; each share is of general payments naming this product in 2020 where a state was reported.

The top 25 states, free in the app

1,454 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2020

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record